United States · FDA National Drug Code directory
Doxepin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64380-203_b6b0f575-6e3a-4011-b33f-a051103058c2
- Product NDC
- 64380-203
- Form
- TABLET
- Composition / generic term
- doxepin hydrochloride
- Labeler
- Strides Pharma Science Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220912
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (64380-203-01) · 64380-203-01
- 100 TABLET in 1 BOTTLE, PLASTIC (64380-203-02) · 64380-203-02
- 500 TABLET in 1 BOTTLE, PLASTIC (64380-203-03) · 64380-203-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →